Epstein Secrets

and the context of trial. The Government moves to exclude the testimony of Bennett Gershman in its entirety. As explained in the notice, Professor Gershman "is a leading authority on prosecutorial misconduct." Notice at 12. The Defense expects that he will testify "on best practices to ensure the integ

guilt. Id. at 19 (quoting United States v. Duncan, No. 18-CR-289, 2019 WL 2210663 (S.D.N.Y. 2019)). The Court concludes that the expected topics of Gershman's testimony—investigation, witness preparation, media contact, being neutral and accurate, and relationships with victims-all fall within the rubric

ent's expert witness, Dr. Lisa Rocchio. The Government on November 8, 2021, filed a motion to partially preclude the testimony of Dr. Dietz and Dr. Loftus. Dkt. No. 424. The Court has already addressed that motion. On November 15, 2021, the Government moved to fully or partially preclude the testimony

rs.com/article/us-health-coronavirus-vaccines-modema/modema-files-for- u-s-vaccine-authorization-will-seek-eu-nod-idUSKEN28AIIU> (11/30, Steenhuysen, Erman) reports the FDA "said an advisory committee would meet to discuss the request on Dec. 17, making Modema's candidate the second highly effective va

d the Wall Street Journal <https://www.wsj.corn/articles/modema-to-ask-health-regulators-to-authorize-its-covid-19-vaccine- 11606737602> (11/30, Al, Loftus, Subscription Publication, 7.57M), "I think this vaccine is going to be really a game changer for this pandemic." Bancel added, "We think it can rea

for Emergency Vaccine Approval.. @US_FDA MUST ACT QUICKLY!!! Operation Warp Speed has been a great modern day miracle." Reuters (11/30, Steenhuysen, Erman) reports the FDA "said an advisory committee would meet to discuss the request on Dec. 17, making Moderna's candidate the second highly effective v

accinations "may be given as early as Dec. 21 if the process goes smoothly and approval is granted." Bancel told the Wall Street Journal (11/30, Al, Loftus, Subscription Publication, 7.57M), "I think this vaccine is going to be really a game changer for this pandemic." Bancel added, "We think it can re

inside. So you cover that up, and the virus has nowhere to go." State AGs Want US To Break Gilead Patent On Remdesivir. Reuters (8/4, Maddipatla, Erman) reports "a bipartisan group" of more than 30 state attorneys general on Tuesday "urged the U.S. government to allow other companies," in addition t

coronavirus infections." The Times adds that Novavax "has never brought a vaccine to market in its 33-year history." The Wall Street Journal (8/4, Loftus, Subscription Publication, 7.57M) also covers the results. NIH, Eli Lilly Seeking Volunteers For Antibody Drug Trials. On NBC Nightly NewsVi (8/4,

aluation, disclosures made by Ms. and the fact that Ms. did not identify Ms. Maxwell as a perpetrator of any abuse. D. Bennett Gershman Professor Gershman is a Distinguished Professor of Law at the Elisabeth Haub School of Law of Pace University since its founding as the Pace Law School in 1976. He has

h counsel, submit the following summary pursuant to Fed. R. Crim. P. 16(b)(1)(C). I. EXPERT DISCLOSURE BY THE DEFENSE A. Dr. Elizabeth Loftus Dr. Loftus is the Distinguished Professor of Psychological Science and Law at the University of California, Irvine School of Law. Dr. Loftus is one of the nati

diagnoses contained in his report. the bases for those opinions, and the significance of the diagnoses and opinions. D. Bennett Gershman Professor Gershman is a Distinguished Professor of Law at the Elisabeth Haub School of Law of Pace University since its founding as the Pace Law School in 1976. He has

h counsel, submit the following summary pursuant to Fed. R. Crim. P. 16(b)(1)(C). I. EXPERT DISCLOSURE BY THE DEFENSE A. Dr. Elizabeth Loftus Dr. Loftus is the Distinguished Professor of Psychological Science and Law at the University of California, Irvine School of Law. Dr. Loftus is one of the nati

diagnoses contained in his report, the bases for those opinions, and the significance of the diagnoses and opinions. D. Bennett Gershman Professor Gershman is a Distinguished Professor of Law at the Elisabeth Haub School of Law of Pace University since its founding as the Pace Law School in 1976. He has

h counsel, submit the following summary pursuant to Fed. R. Crim. P. 16(b)(1)(C). I. EXPERT DISCLOSURE BY THE DEFENSE A. Dr. Elizabeth Loftus Dr. Loftus is the Distinguished Professor of Psychological Science and Law at the University of California, Irvine School of Law. Dr. Loftus is one of the nati

ding the evaluation, disclosures made b nd the fact that did not identify Ms. Maxwell as a perpetrator o any a use. D. Bennett Gershman Professor Gershman is a Distinguished Professor of Law at the Elisabeth Haub School of Law of Pace University since its founding as the Pace Law School in 1976. He has

h counsel, submit the following summary pursuant to Fed. R. Crim. P. 16(b)(1)(C). I. EXPERT DISCLOSURE BY THE DEFENSE A. Dr. Elizabeth Loftus Dr. Loftus is the Distinguished Professor of Psychological Science and Law at the University of California, Irvine School of Law. Dr. Loftus is one of the nati

for Emergency Vaccine Approval.. @US_FDA MUST ACT QUICKLY!!! Operation Warp Speed has been a great modern day miracle." Reuters (11/30, Steenhuysen, Erman) reports the FDA "said an advisory committee would meet to discuss the request on Dec. 17, making Moderna's candidate the second highly effective v

accinations "may be given as early as Dec. 21 if the process goes smoothly and approval is granted." Bancel told the Wall Street Journal (11/30, Al, Loftus, Subscription Publication, 7.57M), "I think this vaccine is going to be really a game changer for this pandemic." Bancel added, "We think it can re

ent's expert witness, Dr. Lisa Rocchio. The Government on November 8, 2021, filed a motion to partially preclude the testimony of Dr. Dietz and Dr. Loftus. Dkt. No. 424. The Court has already addressed that motion. On November 15, 2021, the Government moved to fully or partially preclude the testimony

and the context of trial. The Government moves to exclude the testimony of Bennett Gershman in its entirety. As explained in the notice, Professor Gershman "is a leading authority on prosecutorial misconduct." Notice at 12. The Defense expects that he will testify "on best practices to ensure the integ

an expert imprimatur on these arguments would only enhance the Rule 403 prejudice. Third, apart from Rule 401 and 403, the Defense's disclosure of Gershman does not satisfy Rule 16. The Defense has listed only the general topics on which Gershman will testify, like "investigation," "media contact," and